ArticleEuropean journal of haematology2020

Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemia.

Nicola Gökbuget et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.